BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32392897)

  • 1. Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge.
    Abbott DM; Bortolotto C; Benvenuti S; Lancia A; Filippi AR; Stella GM
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32392897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Asbestos and Malignant Pleural Mesothelioma: An Iranian Perspective.
    Emami H; Ilbeigi A; Khodadad K
    Asian Pac J Cancer Prev; 2017 Oct; 18(10):2619-2623. PubMed ID: 29072053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel approach.
    Nasreen N; Khodayari N; Mohammed KA
    Am J Cancer Res; 2012; 2(2):222-34. PubMed ID: 22432060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant Mesothelioma - Report of Two Cases with Different Presentations.
    Munot MN; Utpat KV; Desai UD; Joshi JM
    Indian J Occup Environ Med; 2019; 23(2):93-96. PubMed ID: 31619883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant peritoneal mesothelioma: a review.
    Kim J; Bhagwandin S; Labow DM
    Ann Transl Med; 2017 Jun; 5(11):236. PubMed ID: 28706904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
    Thomas A; Karakattu S; Cagle J; Hoskere G
    Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge.
    Bakhshayesh Karam M; Karimi S; Mosadegh L; Chaibakhsh S
    Iran J Radiol; 2016 Jan; 13(1):e10949. PubMed ID: 27110327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.
    Zhang W; Wu X; Wu L; Zhang W; Zhao X
    Ann Transl Med; 2015 Aug; 3(13):182. PubMed ID: 26366399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.
    Rossini M; Rizzo P; Bononi I; Clementz A; Ferrari R; Martini F; Tognon MG
    Front Oncol; 2018; 8():91. PubMed ID: 29666782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Genes-Stemness-Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints.
    Stella GM; Marchiò C; Bari E; Ferrarotti I; Bertuccio FR; Di Gennaro A; Abbott DM; Putignano P; Campo I; Torre ML; Corsico AG
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of malignant pleural mesothelioma in neighbouring villages of Northwestern Greece.
    Constantopoulos SH; Malamou-Mitsi VD; Goudevenos JA; Papathanasiou MP; Pavlidis NA; Papadimitriou CS
    Respiration; 1987; 51(4):266-71. PubMed ID: 3659577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres.
    Proietti L; Spicuzza L; Di Maria A; Polosa R; Sebastian Torres E; Asero V; Di Maria GU
    Monaldi Arch Chest Dis; 2006 Dec; 65(4):210-6. PubMed ID: 17393666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural Mesothelioma with No Asbestos Exposure: A Case Report.
    Batahar SA; Ouradi O; Elidrissi S; Amro L
    J Clin Diagn Res; 2016 Nov; 10(11):OD07-OD08. PubMed ID: 28050426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT findings in malignant pleural mesothelioma related to nonoccupational exposure to asbestos and fibrous zeolite (erionite).
    Erzen C; Eryilmaz M; Kalyoncu F; Bilir N; Sahin A; Baris YI
    J Comput Assist Tomogr; 1991; 15(2):256-60. PubMed ID: 1848247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey.
    Senyiğit A; Babayiğit C; Gökirmak M; Topçu F; Asan E; Coşkunsel M; Işik R; Ertem M
    Respiration; 2000; 67(6):610-4. PubMed ID: 11124642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma.
    Scherpereel A;
    Respir Med; 2007 Jun; 101(6):1265-76. PubMed ID: 17137779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetic susceptibility in the development of malignant pleural mesothelioma: somatic and germline variants, clinicopathological features and implication in practical medical/surgical care: a narrative review.
    Congedo MT; West EC; Evangelista J; Mattingly AA; Calabrese G; Sassorossi C; Nocera A; Chiappetta M; Flamini S; Abenavoli L; Margaritora S; Boccuto L; Lococo F
    J Thorac Dis; 2024 Jan; 16(1):671-687. PubMed ID: 38410609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.
    Martarelli D; Catalano A; Procopio A; Orecchia S; Libener R; Santoni G
    BMC Cancer; 2006 May; 6():130. PubMed ID: 16704740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant pleural mesothelioma: a case report.
    Patel SN; Kettner NW
    J Manipulative Physiol Ther; 2005; 28(9):724-9. PubMed ID: 16326244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.
    Lee LJ; Lin CK; Pan CH; Cheng Y; Chang YY; Liou SH; Wang JD
    BMJ Open; 2018 Dec; 8(12):e021063. PubMed ID: 30530573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.